Niels van de Donk

PROF.DR., (Principal Investigator)

20122020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
2019

Carfilzomib for relapsed and refractory multiple myeloma

Groen, K., van de Donk, N., Stege, C., Zweegman, S. & Nijhof, I. S., 2019, In : Cancer management and research. 11, p. 2663-2675 13 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Immunotherapy in myeloma: how far have we come?

Franssen, L. E., Mutis, T., Lokhorst, H. M. & van de Donk, N. W. C. J., 2019, In : THERAPEUTIC ADVANCES IN HEMATOLOGY. 10, p. 2040620718822660

Research output: Contribution to journalReview articleAcademicpeer-review

International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders

Hillengass, J., Usmani, S., Rajkumar, S. V., Durie, B. G. M., Mateos, M-V., Lonial, S., Joao, C., Anderson, K. C., García-Sanz, R., Serra, E. R., du, J., van de Donk, N., Berdeja, J. G., Terpos, E., Zamagni, E., Kyle, R. A., San Miguel, J., Goldschmidt, H., Giralt, S., Kumar, S. & 15 others, Raje, N., Ludwig, H., Ocio, E., Schots, R., Einsele, H., Schjesvold, F., Chen, W-M., Abildgaard, N., Lipe, B. C., Dytfeld, D., Wirk, B. M., Drake, M., Cavo, M., Lahuerta, J. J. & Lentzsch, S., 1 Jun 2019, In : The Lancet Oncology. 20, 6, p. e302-e312

Research output: Contribution to journalReview articleAcademicpeer-review

Reprint of “Immunomodulatory effects of CD38-targeting antibodies”

van de Donk, N. W. C. J., Jan 2019, In : Immunology Letters. 205, p. 71-77 7 p.

Research output: Contribution to journalReview articleAcademicpeer-review

2018

CD38 antibodies in multiple myeloma: Back to the future

van de Donk, N. W. C. J., Richardson, P. G. & Malavasi, F., 2018, In : Blood. 131, 1, p. 13-29

Research output: Contribution to journalReview articleAcademicpeer-review

CD38 antibodies in multiple myeloma: Mechanisms of action and modes of resistance

van de Donk, N. W. C. J. & Usmani, S. Z., 2018, In : Frontiers in Immunology. 9, SEP, 2134.

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias

Gavriatopoulou, M., Musto, P., Caers, J., Merlini, G., Kastritis, E., van de Donk, N., Gay, F., Hegenbart, U., Hajek, R., Zweegman, S., Bruno, B., Straka, C., Dimopoulos, M. A., Einsele, H., Boccadoro, M., Sonneveld, P., Engelhardt, M. & Terpos, E., 2018, In : Leukemia. 32, 9, p. 1883-1898

Research output: Contribution to journalReview articleAcademicpeer-review

From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives

Gay, F., Engelhardt, M., Terpos, E., Wäsch, R., Giaccone, L., Auner, H. W., Caers, J., Gramatzki, M., van de Donk, N., Oliva, S., Zamagni, E., Garderet, L., Straka, C., Hajek, R., Ludwig, H., Einsele, H., Dimopoulos, M., Boccadoro, M., Kröger, N., Cavo, M. & 3 others, Goldschmidt, H., Bruno, B. & Sonneveld, P., Feb 2018, In : Haematologica. 103, 2, p. 197-211 15 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

Immunomodulatory effects of CD38-targeting antibodies

van de Donk, N. W. C. J., 2018, In : Immunology Letters. 199, p. 16-22

Research output: Contribution to journalReview articleAcademicpeer-review

Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network

Ludwig, H., Delforge, M., Facon, T., Einsele, H., Gay, F., Moreau, P., Avet-Loiseau, H., Boccadoro, M., Hajek, R., Mohty, M., Cavo, M., Dimopoulos, M. A., San-Miguel, J. F., Terpos, E., Zweegman, S., Garderet, L., Mateos, M-V., Cook, G., Leleu, X., Goldschmidt, H. & 12 others, Jackson, G., Kaiser, M., Weisel, K., van de Donk, N. W. C. J., Waage, A., Beksac, M., Mellqvist, U. H., Engelhardt, M., Caers, J., Driessen, C., Bladé, J. & Sonneveld, P., 2018, In : Leukemia. 32, 7, p. 1542-1560

Research output: Contribution to journalReview articleAcademicpeer-review

2012

Monoclonal antibody-based therapy as a new treatment strategy in multiple myeloma

Van De Donk, N. W. C. J., Kamps, S., Mutis, T. & Lokhorst, H. M., 1 Feb 2012, In : Leukemia. 26, 2, p. 199-213 15 p.

Research output: Contribution to journalReview articleAcademicpeer-review